- Benchmark ASINB0FDTZ8Y5Q
- MarketplaceUS
- Category ID7792528011
- Analyzed Products
- Keywordfacial skin care
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-30
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，已经是明显的拥挤市场，利润和增长都在被品牌力与价格战挤压。对大品牌来说，只有能砸出明显差异化、研发和投放预算的情况下才勉强有机会；对小商家来说，结论更直接：不适合。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing不建议进入，这个市场已经明显偏向价格战和品牌战，整体对新卖家并不友好。 用户预算500,000 CNY可以覆盖单个ASIN的前期入场，但不代表足够撑起后续研发、品牌和认证；更关键的是，市场新产品盈利率只有25.00%，整体可盈利产品比例也只有32.65%，而且近几个月新增新品里亏损/不盈利的数量持续偏多，说明竞争在加剧。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?53.57%New listing success rate (old brands):6.67%New listing success rate (new brands):46.15%Which new brands have these successful new listings?...Which old brands have these successful new listings?Other major expensesR&DAlternatives- 爽肤水/化妆水型保湿产品：如果用户只是想要“补水+舒缓”，这类产品通常更便宜、使用门槛更低，也更容易在日常护肤里替代精华的部分保湿需求。
- 多功能面霜/保湿乳：对预算敏感或护肤步骤想简化的用户，面霜能同时承担保湿、修护和一定的屏障支持，往往比单独买精华更省事。
- 基础型透明质酸精华：如果核心需求只是补水，而不是更复杂的复合功效，单一成分的基础保湿精华通常更便宜、也更容易选购和搭配。
- 含神经酰胺的修护类乳液：适合把重点放在皮肤屏障维护而非“高活性成分叠加”的用户，通常更温和、也更适合长期低成本使用。
- 片状面膜或补水面膜：当用户需要的是短期快速补水体验时，面膜属于低决策成本替代，使用简单，单次感知效果明显。
- 旅行装/小样套装：如果用户还在试错阶段，不想直接买正装精华，可以先用小样或套装验证肤感与耐受性，降低购买风险。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入：已经明显过度拥挤，且正在进入价格战区。 现在看，新品牌进入数量已经达到10个，落在过度拥挤警戒线内；新品整体成功率只有25%，而新品牌新品盈利率46.15%，但非盈利新品也高达38.46%，说明不是“好做”，而是“强者才能活”。
从证据看，老牌在新产品上的表现并不稳定：SKIN1004 作为老品牌，7个可识别产品里5个盈利、2个亏损，整体盈利率71.43%，但它的新产品盈利率只有66.7%，且新出单品 B0FDTZ8Y5Q 虽然能做到 23.49% 利润率、每月约 1000 单 / 13.72美元均价，但同品牌也有新款 B0GN893YSB 直接失败，说明这类市场对资金、品牌力和选品微创新要求很高。更关键的是，市场里利润率下限只有 9.91%~23.54%，这意味着大量新品已接近低利润边缘；再加上主要成功款里，Dr.Althea 的 B0FMXQBQLX 只有 240 评论却能做到 26.88% 利润率和每月约 900 单 / 17.76美元均价，这是典型可复制的高辨识度韩系清爽修护路线，但它依赖明显的品牌感与配方差异，不是普通小卖家轻易能复制。反面例子也很明确：mopayzer 两个新品 B0GCJ9W2H4、B0GCH77DRX 都失败，品牌新品盈利率 0%、总收入 0，说明没有差异化和启动能力时，进场就是烧钱。
结论很直接：不要进。 如果你是大品牌，只有在能承受高研发、强品牌投放、并且做出明显差异化的前提下才“勉强可能”；如果你是小商家，这个市场不适合你，成功案例太少，而且没有足够多真正的低评论、低预算、可复制的小商家胜出样本。可参考的标杆是：大品牌看 SKIN1004 的 B07ZKHPV9Y / B0BTRWGQNV / B0FDTZ8Y5Q，小商家唯一较接近的成功样本是 Dr.Althea 的 B0FMXQBQLX；应避免照搬 mopayzer 的 B0GCJ9W2H4 / B0GCH77DRX 这种只有卖点堆砌、没有销量承接的打法。
Most investment in new productsNew products with Highest revenueLeast investment in new productsDr.Althea
Recent Monthly Revenue (USD):$15,984.00(900pcs/month)B0FMXQBQLX (4.5/5 (240 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableOld brand with the most profitable new productsSKIN1004
![SKIN1004 [Hudson's Pick] Madagascar Centella Ampoule, Korean Face Serum with Centella Asiatica for Hydrating & Moisturizing, Soothing Facial Serum for Skin Balance, Korean Skin Care, 1.85 fl.oz, 55ml](https://m.media-amazon.com/images/I/61CIxJ0VQ2L._AC_SY145_.jpg)
Recent Monthly Revenue (USD):$50,240.00(4000pcs/month)B07ZKHPV9Y (4.6/5 (4382 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableRecent Monthly Revenue (USD):$42,180.00(3000pcs/month)B0BTRWGQNV (4.7/5 (4203 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableRecent Monthly Revenue (USD):$13,720.00(1000pcs/month)B0FDTZ8Y5Q (4.3/5 (972 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableLeast profitable new productsmopayzer
Recent Monthly Revenue (USD):-(-)B0GCJ9W2H4 (4.4/5 (26 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (USD):-(-)B0GCH77DRXBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 金色软胶囊剂型很少见，和常见滴管精华差异大
- |
- 外观像精华胶囊，视觉记忆点强，更易吸引点击
- |
- 主打维生素E保湿修护，适合干燥/敏感肌女性
B0G34TMFY2 (4.4/5 (36 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 天然蓝色精华液非常少见，货架上辨识度高
- |
- 韩系极简蓝瓶很有清爽高级感，图片吸引力强
- |
- 补水舒缓+敏感肌友好，需求明确，容易促成购买
B0FMXQBQLX (4.5/5 (240 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing结论很明确：这个市场不适合进入，已经进入低利润、强品牌挤压的高风险状态。 新品里只有25.00%能做到盈利，且大多数新品都落在“暂未形成清晰利润/低销量”的区域；真正能稳定赚钱的，主要是SKIN1004、Dr.Althea这类强品牌或已具备品牌势能的玩家，不是普通小卖家能轻松复制的路径。
Profitability difficultyModerate Risk Due to Price CompetitionAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B07ZKHPV9YSKIN10042019-10-25Yes$12.564000pcs$50240.020.94%$10520.26B0BTRWGQNVSKIN10042023-02-03Yes$14.063000pcs$42180.020.67%$8718.61
B0DQCJ9T9Nmedicube2024-12-13Yes$19.171000pcs$19170.031.36%$6011.72B0FMXQBQLXDr.Althea2025-08-19Yes$17.76900pcs$15984.026.88%$4296.5B0FDTZ8Y5QSKIN10042025-11-06Yes$13.721000pcs$13720.023.49%$3222.83
B0CTCLYSY9SKIN10042024-12-06Yes$12.391000pcs$12390.016.64%$2061.7
B0CTTRDRBKSKIN10042024-09-12Yes$15.67500pcs$7835.023.53%$1843.58
B01B8I3UY0Advanced Clinicals2016-01-29Yes$13.57400pcs$5428.023.04%$1250.62
B0FM2BTQXTSKSOYT2025-09-22Yes$10.35650pcs$6727.514.5%$975.49
B0H3ZMG5PRBarklytic2026-06-04Yes$18.83100pcs$1883.024.9%$468.87
B0G2CKD7M9MAREE2025-12-20Yes$9.84400pcs$3936.011.32%$445.56
B07MJ3PJ2NTIA'M2019-01-06Yes$17.55200pcs$3510.011.92%$418.4
B0GWJDTPSQDOUNIU2026-03-03Yes$15.0975pcs$1131.7522.7%$256.91
B0DRV5J39KAKEASS2024-12-30Yes$15.9950pcs$799.524.23%$193.72B0G34TMFY2BS-MALL2025-11-20Yes$12.2250pcs$611.018.33%$112.0
B0F2MXTV5QGrospe2025-03-27Yes$12.9950pcs$649.516.2%$105.22Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0FMXQBQLXDr.Althea2025-08-19Yes$17.76900pcs$15984.026.88%$4296.5B0FDTZ8Y5QSKIN10042025-11-06Yes$13.721000pcs$13720.023.49%$3222.83B0FM2BTQXTSKSOYT2025-09-22Yes$10.35650pcs$6727.514.5%$975.49B0H3ZMG5PRBarklytic2026-06-04Yes$18.83100pcs$1883.024.9%$468.87B0G2CKD7M9MAREE2025-12-20Yes$9.84400pcs$3936.011.32%$445.56B0GWJDTPSQDOUNIU2026-03-03Yes$15.0975pcs$1131.7522.7%$256.91B0G34TMFY2BS-MALL2025-11-20Yes$12.2250pcs$611.018.33%$112.0#New Product Success Rates
Listing这个市场不适合进入，而且已经接近价格战/过度拥挤状态：新上架里只有25.00%能跑出利润，整体可见盈利产品也只有32.65%，但新品牌新上架的成功率只剩54.55%，旧品牌新上架成功率更低到6.67%。更关键的是，旧品牌里几乎被SKIN1004和Global Beauty Care这类强势玩家压着打，说明新手要么烧钱做差异化，要么直接被挤出局。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
Dr.AltheaSKSOYTBS-MALLMAREEDOUNIUBarklyticSKIN1004Nonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Global Beauty CaremopayzerOther#Success Rate by Entry Time
Listing这个市场现在不值得进入，结论很直接：2025年以来新品进入明显增多，但利润表现没有同步改善，反而更像被价格战和品牌挤压。 目前不是一个适合小品牌或大品牌轻易下注的市场；如果硬要做，只能靠强品牌力、强差异化和更高预算硬推，普通卖家胜率很低。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 2 3 2 0 0 12 2026 0 0 0 0 2 0 0 7 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 1 0 0 3 2025/9 0 0 0 1 0 0 0 4 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 1 1 0 0 1 2025/12 0 0 2 1 0 0 0 4 2026/1 0 0 0 0 0 0 0 1 2026/2 0 0 0 0 0 0 0 2 2026/3 0 0 0 0 1 0 0 1 2026/4 0 0 0 0 0 0 0 1 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 1 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesAdvanced ClinicalsB01B8I3UY0 (4.5/5 (1984 Reviews))Advanced Clinicals Hyaluronic Acid Serum For Face | Moisturizing Facial Skin Care Products | Hydrating Serum For Face Helps Improve Look Of Wrinkles, Fine Lines, & Uneven Dry Skin Texture, 1.75 Fl Oz
This listing is deemed profitablePrice (USD)$13.57Released TypeOld Release (2016-01-29)Brand is an old entry in this marketSize and Weight14.7 x 4.7 x 4.5 cm, 48.00gProfitable Factors
Established brand with longevityBased on old ASINKey Buying Motive
以透明质酸+维生素E+绿茶/藻类等基础保湿抗氧化配方为核心，主打补水、丰盈和细纹改善Target Customers
干燥、缺水、细纹明显且偏好大众熟悉成分的日常补水护理人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$5,428.00400 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight20.88% / 23.04%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight19.02% / 21.18%Peak / Non PeakSales & BSR Performance
SKIN1004B0FDTZ8Y5Q (4.3/5 (972 Reviews))SKIN1004 Retinol 0.2% Boosting Shot Ampoule, Face Serum for Skin Elasticity, Facial Spicule Serum with Retinol & Retinal, Centella Ampoule for Fine Lines & Firmness, Korean Skin Care, 1.01fl.oz / 30ml
This listing is deemed profitablePrice (USD)$13.72Released TypeNew Release (2025-11-06)Brand is an old entry in this marketSize and Weight8.7 x 5.5 x 5.2 cm, 30.00gProfitable Factors
Established brand with longevityBased on old ASINDistinct functions and featuresDesign & Appearance
浅金色/米金色瓶身配暖色滴管，整体更偏高端修护感, 30ml小容量精华，标签极简，强调视黄醇+spicule的功能导向外观Key Buying Motive
视黄醇0.2% + retinal + centella + facial spicule，主打紧致、细纹和弹性修护，差异化强Target Customers
针对想做抗老修护、但又希望比高浓度A醇更温和的人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$13,720.001000 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight21.43% / 23.49%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight19.95% / 22.02%Peak / Non PeakSales & BSR Performance
Loading samples... 25%